Chemically modified Taq polymerase
January 2015—Empirical Bioscience, formerly known as Syzygy Biotech, has introduced FlashTaq Hot-Start Taq DNA Polymerase, a chemically modified Taq polymerase designed to reduce nonspecific amplification in PCR.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace
Medical equipment financing
January 2015—Cornerstone Medical and Technology Finance specializes in assisting small medical practice owners obtain capital. Cornerstone can customize financing programs for pathologists who would like to remodel, expand, or relocate their office or to purchase additional equipment.
Monoclonal antibody patent issued
January 2015—Biocare Medical has been awarded a U.S. patent for its anti-PAX8 mouse monoclonal antibody, clone [BC12]. The PAX8 antibody [BC12] is designed to target a restricted epitope and exhibits higher specificity and provides sharper staining than the PAX8 rabbit polyclonal antibody.
Emergency-use Ebola virus kit
January 2015—Qiagen will offer global distribution of the RealStar Ebolavirus RT-PCR Kit 1.0. The diagnostic kit, developed and manufactured by Altona Diagnostics, is a reverse transcription polymerase chain reaction test intended for the qualitative detection of RNA from all known strains of Ebola viruses. Qiagen will distribute the kit and Altona’s already CE-IVD marked test, the RealStar Filovirus RT-PCR Kit, which is for both Ebola and Marburg viruses and does not fall under the emergency use authorization.
Marketplace Index, Companies “R”
Search our marketplace index for pathology lab products and industry news from dozens of companies.
Advanced Cell Diagnostics awarded NCI grant, 12/14
December 2014—Advanced Cell Diagnostics has been awarded a two-year, $1.4 million grant from the National Cancer Institute under its Small Business Innovation Research Grant phase two program. ACD and its academic partner, Cleveland Clinic, will use the grant to develop and validate a diagnostic test based on ACD’s proprietary RNAscope technology for discriminating various B-cell non-Hodgkin lymphomas from benign lymphoproliferative diseases.
Affymetrix, Ariosa Diagnostics sign supply agreement, 12/14
December 2014—Affymetrix and Ariosa Diagnostics announced the signing of a multiyear supply agreement covering Affymetrix arrays and instruments to be used as part of Ariosa’s Harmony Non-Invasive Prenatal Test. The partnership enables Ariosa to pursue the development of a Harmony test kit that will allow laboratories worldwide to adopt and perform this test.
Reagent kits, 12/14
December 2014—Illumina announced new reagent kits for the HiSeq X Ten and HiSeq 2500 sequencing systems. For HiSeq X Ten Systems, the HiSeq X HD v2 Reagent Kit adds flexibility to population-scale human whole-genome sequencing by supporting an expanded menu of library preparation options.
FDA clearance for hematology workcell solution, 12/14
December 2014—Beckman Coulter Diagnostics received FDA 510(k) clearance for its UniCel DxH v3.0 software, which supports automated connectivity of the UniCel DxH 800 and DxH Slidemaker Stainer Coulter Cellular Analysis Systems.
Next-gen multiplex biomarker analysis platform, 12/14
December 2014—MyCartis announced the launch of Evalution, a digital multiplex analysis platform tailored to clinical research and pharmaceutical markets and designed to analyze a broad range of protein and nucleic-acid-based biomarkers. Evalution provides an integrated reaction and detection environment and simultaneous analysis of large numbers of analytes per assay.